CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
biopsy alone in diagnosing subjects with clinically significant prostate cancer with MRI visible lesions. This study will consist o...
New York, New York, United States and 2 other locations
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
New York, New York, United States and 8 other locations
and docetaxel in patients with newly metastatic, hormone-sensitive prostate cancer (mHSPC), using a primary endpoint of undetectabl...
Phase 2
New York, New York, United States
study is a randomized study that compares 5 radiation therapy treatments to 2 radiation therapy treatments in men with low or intermediate-risk prostate...
Phase 2
New York, New York, United States and 1 other location
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
New York City, New York, United States and 12 other locations
the UroNav software and DynaCAD software for planning and treating prostate cancer as an add on to the already approved workflow of...
New York, New York, United States and 2 other locations
purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...
Phase 1
New York, New York, United States and 7 other locations
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
New York, New York, United States and 92 other locations
pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...
Phase 1
New York, New York, United States and 15 other locations
The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer...
New York, New York, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal